Filter News
Area of Research
- Advanced Manufacturing (6)
- Biological Systems (1)
- Biology and Environment (40)
- Building Technologies (2)
- Clean Energy (95)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (3)
- Energy Sciences (1)
- Fusion and Fission (4)
- Fusion Energy (8)
- Isotopes (2)
- Materials (32)
- Materials for Computing (6)
- National Security (7)
- Neutron Science (16)
- Nuclear Science and Technology (9)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Renewable Energy (1)
- Supercomputing (32)
- Transportation Systems (2)
News Type
News Topics
- (-) Advanced Reactors (23)
- (-) Bioenergy (39)
- (-) Biomedical (28)
- (-) Biotechnology (10)
- (-) High-Performance Computing (39)
- (-) Hydropower (6)
- (-) Sustainable Energy (75)
- (-) Transportation (60)
- 3-D Printing/Advanced Manufacturing (74)
- Artificial Intelligence (43)
- Big Data (24)
- Biology (39)
- Buildings (31)
- Chemical Sciences (38)
- Clean Water (15)
- Climate Change (44)
- Composites (18)
- Computer Science (97)
- Coronavirus (28)
- Critical Materials (23)
- Cybersecurity (20)
- Decarbonization (27)
- Education (3)
- Element Discovery (1)
- Energy Storage (72)
- Environment (78)
- Exascale Computing (10)
- Fossil Energy (2)
- Frontier (16)
- Fusion (23)
- Grid (36)
- Irradiation (2)
- Isotopes (23)
- ITER (5)
- Machine Learning (24)
- Materials (92)
- Materials Science (83)
- Mathematics (2)
- Mercury (5)
- Microelectronics (1)
- Microscopy (27)
- Molten Salt (7)
- Nanotechnology (38)
- National Security (21)
- Net Zero (5)
- Neutron Science (76)
- Nuclear Energy (45)
- Partnerships (28)
- Physics (28)
- Polymers (21)
- Quantum Computing (13)
- Quantum Science (36)
- Renewable Energy (1)
- Security (12)
- Simulation (15)
- Space Exploration (13)
- Statistics (2)
- Summit (27)
- Transformational Challenge Reactor (4)
Media Contacts
Quanex Building Products has signed a non-exclusive agreement to license a method to produce insulating material from ORNL. The low-cost material can be used as an additive to increase thermal insulation performance and improve energy efficiency when applied to a variety of building products.
Researchers at Oak Ridge National Laboratory proved that a certain class of ionic liquids, when mixed with commercially available oils, can make gears run more efficiently with less noise and better durability.
Electro-Active Technologies, Inc., of Knoxville, Tenn., has exclusively licensed two biorefinery technologies invented and patented by the startup’s co-founders while working at the Department of Energy’s Oak Ridge National Laboratory. The technologies work as a system that converts organic waste into renewable hydrogen gas for use as a biofuel.
Using additive manufacturing, scientists experimenting with tungsten at Oak Ridge National Laboratory hope to unlock new potential of the high-performance heat-transferring material used to protect components from the plasma inside a fusion reactor. Fusion requires hydrogen isotopes to reach millions of degrees.
A new method developed at Oak Ridge National Laboratory improves the energy efficiency of a desalination process known as solar-thermal evaporation.
A team of scientists led by Oak Ridge National Laboratory have discovered the specific gene that controls an important symbiotic relationship between plants and soil fungi, and successfully facilitated the symbiosis in a plant that
A team of researchers at Oak Ridge National Laboratory have demonstrated that designed synthetic polymers can serve as a high-performance binding material for next-generation lithium-ion batteries.
For the first time, Oak Ridge National Laboratory has completed testing of nuclear fuels using MiniFuel, an irradiation vehicle that allows for rapid experimentation.
In a step toward advancing small modular nuclear reactor designs, scientists at Oak Ridge National Laboratory have run reactor simulations on ORNL supercomputer Summit with greater-than-expected computational efficiency.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.